Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Alcohol Clin Exp Res. 2012 May 2;36(11):2000–2007. doi: 10.1111/j.1530-0277.2012.01807.x

Table 2.

Alcohol consumption during the 5-day natural observation period and after the priming drink in the bar-lab based on OPRM1 genotype and medication group. Asp40 indicates either heterozygous (asn40asp) or homozygous (asp40asp) at the OPRM1 118 locus.

Naltrexone Placebo F (df 1,79) P
asn40asn asp40 asn40asn asp40
N 19 19 21 24
5 Day Drinking:
 Drinks/Day 4.7 ± 1.8 5.7 ± 3.2 6.2 ± 3.4 6.3 ± 3.7 0.44 0.51
 Heavy Drinking
 Days (%)
44 ± 21 53 ± 27 53 ± 24 52 ± 27 0.85 0.36
Bar Lab Drinks 3.0 ± 2.9 3.8 ± 3.1 3.8 ± 2.8 3.1 ± 3.3 1.20 0.28